MedPath

A CLINICAL TRIAL TO STUDY THE EFFECT OF TWO DRUGS, FERRIC-CARBOXY MALTOSE AND IRON SUCROSE COMPLEX FOR TREATMENT OF IRON DEFICIENCY ANEMIA IN PREGNANT WOME

Phase 3
Conditions
Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium
Registration Number
CTRI/2023/02/049803
Lead Sponsor
BPS Govt. Medical College for Women, Khanpur kalan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Ante-partum women

Age between 18 to 35 years.

Hemoglobin between 6-9.9 gm %..

Iron deficiency anemia

24-34 weeks of period of gestation

Exclusion Criteria

Other than Iron Deficiency Anemia

Acute or Chronic Liver diseases

HIV

1st Trimester of Pregnancy

Serum transaminases > 1.5 times upper limit of normal

Serum Creatinine > 2.0 mg/dL

History of allergic reaction to intravenous iron infusion

Anemia due to other causes Thalassemia patient

Iron metabolic disorder

Hemosiderosis

Hemochromatosis

Untreated Pyelonephritis

Anaphylactic Reaction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath